MEDICURE INC. Files November 2025 6-K Report

Ticker: MCUJF · Form: 6-K · Filed: Nov 19, 2025 · CIK: 1133519

Medicure Inc 6-K Filing Summary
FieldDetail
CompanyMedicure Inc (MCUJF)
Form Type6-K
Filed DateNov 19, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, disclosure

TL;DR

MEDICURE INC. filed its monthly 6-K report on Nov 19, 2025, confirming its status as a foreign private issuer.

AI Summary

On November 19, 2025, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of November 2025 and indicates that MEDICURE INC. is a foreign private issuer filing under the 1934 Act. The company's principal executive offices are located at 2-1250 Waverley Street, Winnipeg, MB, Canada.

Why It Matters

This filing provides routine disclosure for MEDICURE INC. as a foreign private issuer, informing investors about its ongoing reporting status.

Risk Assessment

Risk Level: low — This filing is a routine monthly report for a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

  • MEDICURE INC. (company) — Filer of the 6-K report
  • November 2025 (date) — Reporting period for the 6-K
  • 20251119 (date) — Filing date of the 6-K
  • 001-31995 (company) — SEC Commission File Number for MEDICURE INC.
  • 2-1250 Waverley Street Winnipeg, MB Canada R3T 6C6 (company) — Principal executive offices address

FAQ

What type of SEC filing is MEDICURE INC. submitting?

MEDICURE INC. is submitting a Form 6-K, which is a Report of Foreign Private Issuer.

For what period is this Form 6-K report intended?

This Form 6-K report is for the month of November 2025.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is November 19, 2025.

Where are MEDICURE INC.'s principal executive offices located?

MEDICURE INC.'s principal executive offices are located at 2-1250 Waverley Street, Winnipeg, MB, Canada R3T 6C6.

Does MEDICURE INC. file annual reports under Form 20-F or Form 40-F?

MEDICURE INC. indicates it files annual reports under cover of Form 20-F.

Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-11-19 16:41:16

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: November 19, 2025 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.